New study a "valuable resource" for predicting CVD costs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.633, 2011-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concomitant BPH and CVD beef up costs in the US

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness of Long-Acting Risperidone in New Zealand: A Report of Resource Utilization and Costs in a 12-Month Mirror-Image Analysis

By Carswell Christopher Wheeler Amanda Vanderpyl Jane

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 777-787

Adis International

Access to resources Recommend Favorite

Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs

By Whalley Simon Puvanachandra Prasanthi Desai Atman Kennedy Hugh

Clinical Medicine, Vol. 7, Iss. 2, 2007-04 ,pp. : 119-124

Royal College Of Physicians

Access to resources Recommend Favorite

Predicting antihypertensive drug use and costs in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 289, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pain severity predicts resource use, costs in IBS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 410, 2003-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite